Changing appetites: The adaptive advantages of fuel choice

Trends in Cell Biology

Volumn 24, Issue 2, 2014, Pages 118-127

  Stanley, Illana A ^a,b   Ribeiro, Sofia M ^a,c,d   Giménez Cassina, Alfredo ^a,b   Norberg, Erik ^a,b   Danial, Nika N ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Biosynthesis; Metabolism; Mitochondria; Nutrients; Stress responses; Substrate supply

Indexed keywords

2 OXOGLUTARIC ACID; 3 HYDROXY 3 METHYLGLUTARYL COENZYME A; 3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; ACETYL COENZYME A; ACYL COENZYME A; ACYLCARNITINE; AMINO ACID; CARBON; CITRIC ACID; FATTY ACID; FUMARIC ACID; GLUCOSE; GLUTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ISOCITRIC ACID; KETONE; KETONE BODY; MALIC ACID; OXALOACETIC ACID; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUCCINIC ACID;

ADAPTATION; BIOSYNTHESIS; CELL COMPARTMENTALIZATION; CELL CYCLE; CELL ENERGY; CELL FATE; CELL FUNCTION; CELL INTERACTION; CELL METABOLISM; CELL PROLIFERATION; CELL STRESS; CELLULAR STRESS RESPONSE; DNA DAMAGE; FATTY ACID METABOLISM; GENOTOXICITY; GLUCOSE METABOLISM; HUMAN; KETOGENESIS; MALADJUSTMENT; METABOLIC REGULATION; MITOCHONDRION; NERVE EXCITABILITY; NONHUMAN; NUTRIENT AVAILABILITY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW;

BIOSYNTHESIS; METABOLISM; MITOCHONDRIA; NUTRIENTS; STRESS RESPONSES; SUBSTRATE SUPPLY;

CELL DIFFERENTIATION; CELLS; ENERGY METABOLISM; HUMANS;

EID: 84892977418     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2013.07.010     Document Type: Review

References (96)

1. Eliasson P., Jönsson J-I. The hematopoietic stem cell niche: Low in oxygen but a nice place to be. J. Cell. Physiol. 2010, 222:17-22.
2. Rafalski V.A., Brunet A. Energy metabolism in adult neural stem cell fate. Prog. Neurobiol. 2011, 93:182-203.
3. Folmes C.D., et al. Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell 2012, 11:596-606.
4. Folmes C.D., et al. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011, 14:264-271.
5. Lonergan T., et al. Differentiation-related changes in mitochondrial properties as indicators of stem cell competence. J. Cell. Physiol. 2006, 208:149-153.
6. Varum S., et al. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS ONE 2011, 6:e20914.
7. Chen C-T., et al. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 2008, 26:960-968.
8. Ito K., et al. A PML-PPAR-[delta] pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. Nat. Med. 2012, 18:1350-1358.
9. Simsek T., et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 2010, 7:380-390.
10. Zhou W., et al. HIF1alpha induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. EMBO J. 2012, 31:2103-2116.
11. Wang J., et al. Dependence of mouse embryonic stem cells on threonine catabolism. Science 2009, 325:435-439.
12. Alexander P.B., et al. Targeted killing of a mammalian cell based upon its specialized metabolic state. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:15828-15833.
13. Shyh-Chang N., et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 2013, 339:222-226.
14. MacIver N.J., et al. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 2013, 31:259-283.
15. Michalek R.D., et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 2011, 186:3299-3303.
16. Delgoffe G.M., et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 2011, 12:295-303.
17. van der Windt G.J., et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 2012, 36:68-78.
18. Lunt S.Y., Vander Heiden M.G. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 2011, 27:441-464.
19. Locasale J.W., Cantley L.C. Metabolic flux and the regulation of mammalian cell growth. Cell Metab. 2011, 14:443-451.
20. Knobloch M., et al. Metabolic control of adult neural stem cell activity by Fasn-dependent lipogenesis. Nature 2013, 493:226-230.
21. Gnoni G.V., et al. The mitochondrial citrate carrier: metabolic role and regulation of its activity and expression. IUBMB Life 2009, 61:987-994.
22. Caro P., et al. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 2012, 22:547-560.
23. Marin-Valencia I., et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab. 2012, 15:827-837.
24. Metallo C.M., et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 2012, 481:380-384.
25. Wise D.R., et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:19611-19616.
26. Mullen A.R., et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2012, 481:385-388.
27. Tibbetts A.S., Appling D.R. Compartmentalization of mammalian folate-mediated one-carbon metabolism. Annu. Rev. Nutr. 2010, 30:57-81.
28. Jain M., et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012, 336:1040-1044.
29. Maddocks O.D., et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 2013, 493:542-546.
30. Possemato R., et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011, 476:346-350.
31. Locasale J.W., et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 2011, 43:869-874.
32. Chaneton B., et al. Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 2012, 491:458-462.
33. Ye J., et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:6904-6909.
34. Lemons J.M., et al. Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol. 2010, 8:e1000514.
35. Salpeter S.J., et al. Glucose regulates cyclin D2 expression in quiescent and replicating pancreatic beta-cells through glycolysis and calcium channels. Endocrinology 2011, 152:2589-2598.
36. Metukuri M.R., et al. ChREBP mediates glucose-stimulated pancreatic beta-cell proliferation. Diabetes 2012, 61:2004-2015.
37. Diaz-Moralli S., et al. Target metabolomics revealed complementary roles of hexose- and pentose-phosphates in the regulation of carbohydrate-dependent gene expression. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E234-E242.
38. Arden C., et al. Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. Biochem. J. 2012, 443:111-123.
39. Guinez C., et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 2011, 60:1399-1413.
40. Salpeter S.J., et al. Glucose and aging control the quiescence period that follows pancreatic beta cell replication. Development 2010, 137:3205-3213.
41. Moncada S., et al. Fulfilling the metabolic requirements for cell proliferation. Biochem. J. 2012, 446:1-7.
42. Carracedo A., et al. A metabolic prosurvival role for PML in breast cancer. J. Clin. Investig. 2012, 122:3088-3100.
43. Zaugg K., et al. Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev. 2011, 25:1041-1051.
44. Samudio I., et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J. Clin. Investig. 2010, 120:142-156.
45. Nieman K.M., et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 2011, 17:1498-1503.
46. Pike L.S., et al. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim. Biophys. Acta 2011, 1807:726-734.
47. Schafer Z.T., et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 2009, 461:109-113.
48. Jeon S-M., et al. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 2012, 485:661-665.
49. Anastasiou D., et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011, 334:1278-1283.
50. Jiang P., et al. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat. Cell Biol. 2011, 13:310-316.
51. Cosentino C., et al. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J. 2011, 30:546-555.
52. Jeong, Seung M., et al. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 2013, 23:450-463.
53. Harper M.E., et al. Characterization of a novel metabolic strategy used by drug-resistant tumor cells. FASEB J. 2002, 16:1550-1557.
54. Ashrafian H., et al. Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway. Cell Metab. 2012, 15:361-371.
55. Adam J., et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 2011, 20:524-537.
56. Thiele E.A. Assessing the efficacy of antiepileptic treatments: the ketogenic diet. Epilepsia 2003, 44(Suppl. 7):26-29.
57. Lutas A., Yellen G. The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 2013, 36:32-40.
58. Shimazu T., et al. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 2013, 339:211-214.
59. Jarrett S.G., et al. The ketogenic diet increases mitochondrial glutathione levels. J. Neurochem. 2008, 106:1044-1051.
60. Bough K.J., et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 2006, 60:223-235.
61. Garriga-Canut M., et al. 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 2006, 9:1382-1387.
62. Giménez-Cassina A., et al. BAD-dependent regulation of fuel metabolism and KATP channel activity confers resistance to epileptic seizures. Neuron 2012, 74:719-730.
63. Blázquez C., et al. Role of carnitine palmitoyltransferase I in the control of ketogenesis in primary cultures of rat astrocytes. J. Neurochem. 1998, 71:1597-1606.
64. Westermann B. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 2010, 11:872-884.
65. Liesa M., Shirihai O.S. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 2013, 17:491-506.
66. Twig G., et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 2008, 27:433-446.
67. Gomes L.C., et al. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 2011, 13:589-598.
68. Molina A.J., et al. Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes 2009, 58:2303-2315.
69. Rambold A.S., et al. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:10190-10195.
70. Rossignol R., et al. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 2004, 64:985-993.
71. Wang H., et al. Perilipin 5, a lipid droplet-associated protein, provides physical and metabolic linkage to mitochondria. J. Lipid Res. 2011, 52:2159-2168.
72. Marcondes M.C., et al. Muscle-type 6-phosphofructo-1-kinase and aldolase associate conferring catalytic advantages for both enzymes. IUBMB Life 2011, 63:435-445.
73. Baltrusch S., Tiedge M. Glucokinase regulatory network in pancreatic β-cells and Liver. Diabetes 2006, 55:S55-S64.
74. Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem. J. 2008, 414:1-18.
75. Danial N.N., et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 2003, 424:952-956.
76. Danial N.N., et al. Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nat. Med. 2008, 14:144-153.
77. Genda E.N., et al. Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria. J. Neurosci. 2011, 31:18275-18288.
78. Hall C.N., et al. Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing. J. Neurosci. 2012, 32:8940-8951.
79. Zala D., et al. Vesicular glycolysis provides on-board energy for fast axonal transport. Cell 2013, 152:479-491.
80. Wallimann T., et al. The creatine kinase system and pleiotropic effects of creatine. Amino Acids 2011, 40:1271-1296.
81. Thomas A.P., Halestrap A.P. Identification of the protein responsible for pyruvate transport into rat liver and heart mitochondria by specific labelling with [3H]N-phenylmaleimide. Biochem. J. 1981, 196:471-479.
82. Bricker D.K., et al. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 2012, 337:96-100.
83. Herzig S., et al. Identification and functional expression of the mitochondrial pyruvate carrier. Science 2012, 337:93-96.
84. Palmieri F., Pierri C.L. Mitochondrial metabolite transport. Essays Biochem. 2010, 47:37-52.
85. Divakaruni A.S., et al. Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:5422-5427.
86. Gottlieb R.A., Gustafsson A.B. Mitochondrial turnover in the heart. Biochim. Biophys. Acta 2011, 1813:1295-1301.
87. Twig G., Shirihai O.S. The interplay between mitochondrial dynamics and mitophagy. Antioxid. Redox Signal. 2011, 14:1939-1951.
88. Chen Y., Dorn G.W. PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 2013, 340:471-475.
89. Narendra D., et al. Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. Cold Spring Harb. Perspect. Biol. 2012, 4:1-11.
90. Haddad D.M., et al. Mutations in the intellectual disability gene ube2a cause neuronal dysfunction and impair parkin-dependent mitophagy. Mol. Cell 2013, 50:831-843.
91. Melser S., et al. Rheb regulates mitophagy induced by mitochondrial energetic status. Cell Metab. 2013, 17:719-730.
92. Liu L., et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 2012, 14:177-185.
93. Glick D., et al. BNip3 regulates mitochondrial function and lipid metabolism in the liver. Mol. Cell. Biol. 2012, 32:2570-2584.
94. Lee K., et al. Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex. J. Biol. Chem. 2011, 286:25655-25662.
95. Hoppel C., et al. Rat liver mitochondrial contact sites and carnitine palmitoyltransferase-I. Arch. Biochem. Biophys. 2001, 392:321-325.
96. Quiros P.M., et al. Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice. EMBO J. 2012, 31:2117-2133.